From The Stage

Difference Between Biobetters and Biosimilars

Posted by BioAgilytix / / Biomarkers, Biosimilars

According to research compiled by Reports and Data, in 2018 the global biologics market was valued at over $250 million, but is projected to reach an estimated $625 million by the end of 2026 with an 11.9% compound annual growth rate (CAGR). Biologics are medications made up of proteins, sugars, or DNA, and oftentimes are a complex combination of these materials and by-products. Biologics can also be composed of living cells and tissues and come in a wide variety of products such as allergy medicines, vaccines, oncology treatments, therapeutics, amongst…